Chemical Approaches for Studying the Biology and Pharmacology of Membrane Transporters: The Histidine/Large Amino Acid Transporter SLC7A5 as a Benchmark
Химические подходы к изучению биологии и фармакологии мембранных транспортеров: транспортер гистидина и крупных аминокислот SLC7A5 как эталонная модель
2021-10-29
SCID: 54.1/s46k7u9k
Discuss with AI
SLC7A5/LAT1chemical modificationdrug transportmembrane transporterssubstrate binding site
Figures from the paper
Abstract (AI)
The localization of membrane transporters at the forefront of natural barriers makes these proteins very interesting due to their involvement in the absorption and distribution of nutrients and xenobiotics, including drugs. Over the years, structure/function relationship studies have been performed employing several strategies, including chemical modification of exposed amino acid residues. These approaches are very meaningful when applied to membrane transporters, given that these proteins are characterized by both hydrophobic and hydrophilic domains with a different degree of accessibility to employed chemicals. Besides basic features, the chemical targeting approaches can disclose information useful for pharmacological applications as well. An eminent example of this picture is the histidine/large amino acid transporter SLC7A5, known as LAT1 (Large Amino Acid Transporter 1). This protein is crucial in cell life because it is responsible for mediating the absorption and distribution of essential amino acids in peculiar body districts, such as the blood brain barrier and placenta. Furthermore, LAT1 can recognize a large variety of molecules of pharmacological interest and is also considered a hot target for drugs due to its over-expression in virtually all human cancers. Therefore, it is not surprising that the chemical targeting approach, coupled with bioinformatics, site-directed mutagenesis and transport assays, proved fundamental in describing features of LAT1 such as the substrate binding site, regulatory domains and interactions with drugs that will be discussed in this review. The results on LAT1 can be considered to have general applicability to other transporters linked with human diseases.
Key Findings
1
Chemical targeting of exposed amino acid residues is a valuable strategy for investigating membrane-transporter structure–function relationships across hydrophobic and hydrophilic domains.
2
Combining chemical targeting with bioinformatics, site-directed mutagenesis, and transport assays revealed LAT1 substrate-binding features, regulatory domains, and drug interactions.
3
Insights obtained from LAT1 chemical studies may be broadly applicable to other membrane transporters associated with human diseases.
4
LAT1 mediates essential amino-acid absorption and distribution in specialized barriers and tissues, including the blood–brain barrier and placenta.
5
LAT1 recognizes diverse pharmacologically relevant molecules and is a prominent drug target because it is overexpressed in virtually all human cancers.
Research Object
The histidine/large amino acid transporter SLC7A5 (LAT1)
Research Subject
LAT1’s structure–function features, including its substrate-binding site, regulatory domains, and interactions with pharmacologically relevant drugs
Publication Details
Publication Date
2021-10-29
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health2018
Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)2017
A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT12019